HIGHLIGHTS
- who: Jo-Ni Hung from the Scientific Institute of Romagna for the (IRCCS), Italy Agostino Gemelli University Polyclinic have published the article: Real-World Efficacy of Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer, in the Journal: (JOURNAL)
- what: This study investigated the efficacy of adding bevacizumab to chemotherapy and compared it with that of chemotherapy alone in patients with recurrent EOC by using real-world data from an Asian population. Subgroup analysis was conducted to determine if a significant variation was present in the aforementioned association.
- how: The authors conducted a retrospective . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.